title: GI events leading to death in association with celecoxib and rofecoxib.
authors.forename: J
authors.initials: J
authors.lastname: Weaver
authors.forename: R A
authors.initials: RA
authors.lastname: Bonnel
authors.forename: C B
authors.initials: CB
authors.lastname: Karwoski
authors.forename: A D
authors.initials: AD
authors.lastname: Brinker
authors.forename: J
authors.initials: J
authors.lastname: Beitz
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000401:mortality*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008875:Middle Aged; D011720:Pyrazoles; D013449:Sulfonamides / Q000009:adverse effects*; D013450:Sulfones
chemical_list: D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib